Full-Time

Sr. Associate Engineer

Polysaccharide Process Development

Updated on 4/25/2024

Vaxcyte

Vaxcyte

201-500 employees

Develops broad-spectrum pneumococcal conjugate vaccines

Biotechnology

Mid

San Carlos, CA, USA

Required Skills
Python
R
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • B.S./M.S. in bioengineering, chemical engineering, biochemistry or related disciplines with 3+ years of experience
  • Prior experience with bioreactor fermentations, depth filtration, centrifugation, and TFF for primary recovery
  • Experience with analytical methods such as plate-based assays, UV-spectrophotometry, and metabolite analyzers
  • Experience writing technical documents including lab operation protocols and data summary reports
  • Proficiency in Microsoft Excel, Word, and Powerpoint
  • Experience with statistical software such as JMP, R studio, python, etc.
  • Familiarity with statistical methods for process characterization and validation
  • Familiarity with DOE principles and experience with DoE software (JMP)
  • Some experience with GXP requirements including deviation investigations, CAPAs, and change controls
  • Understanding of engineering principles for scaling upstream unit operations
Responsibilities
  • Assist in designing and executing process development runs
  • Operate and maintain instrumentation including BSL2 microbial fermenters, TFF systems, depth filtration, and centrifugation
  • Record data in electronic laboratory notebooks and write technical summary reports
  • Perform analytical assays for process development and in-process manufacturing samples
  • Perform statistical analysis for manufacturing in-process data
  • Present data to the team and contribute to technical discussions
  • Review manufacturing documents and transfer in-process data to repositories

Vaxcyte is dedicated to developing a range of high-fidelity, broad-spectrum vaccines, including VAX-24, a 24-valent pneumococcal conjugate vaccine. Leveraging advanced chemistry and the proprietary XpressCF™ cell-free protein synthesis platform, the company stands out in the biotechnology field for its targeted approach to combating serious bacterial infections. This focus on cutting-edge technology and a strong pipeline of innovative vaccine candidates makes it an exciting workplace for professionals passionate about impacting global health through scientific breakthroughs.

Company Stage

IPO

Total Funding

$2.3B

Headquarters

San Carlos, California

Founded

2013

Growth & Insights
Headcount

6 month growth

25%

1 year growth

60%

2 year growth

150%